ArticleNanomedicine (London, England)2024

Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer.

Druva Sarika Rongala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.